PDGF Scaffold for Endogenous Cell Recruitment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cell transplantation methods for tissue regeneration face challenges such as immune rejection, pathogen transmission, tumorigenesis, and regulatory hurdles, and require complex packaging, shipping, and clinical adoption, while recruiting endogenous progenitor cells for tissue repair is a discussed but not effectively implemented approach.
Innovation Solution
A method using a scaffold with platelet-derived growth factor (PDGF) to induce the migration of endogenous progenitor cells, such as alveolar stem cells, to damaged tissues, where PDGF is incorporated at concentrations effective for cell recruitment and tissue regeneration, potentially avoiding the need for transplanted cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If transplanted cells are used for tissue regeneration, then tissue repair can be achieved, but immune rejection, pathogen transmission, and tumorigenesis occur
Solution Approach 1:
The invention utilizes the host's own endogenous progenitor cells to regenerate damaged tissue, eliminating the need for external cell transplantation. The scaffold with PDGF coating activates and directs the host's natural repair mechanisms, thereby avoiding immune rejection and pathogen transmission associated with allogeneic or xenogeneic cell transplants
2Reliability
If cell transplantation is performed, then tissue regeneration can occur, but complex packaging, shipping, and regulatory approval processes are required
Solution Approach 1:
By eliminating the need for cell transplantation and utilizing endogenous cells instead, the invention removes the entire cell handling supply chain including harvesting, packaging, shipping, storage, and regulatory approval processes, significantly simplifying the treatment protocol
Solution Approach 2:
The invention extracts and removes the complex cell transplantation process from the tissue regeneration protocol, retaining only the essential scaffold implantation step while eliminating the need for cell processing and regulatory hurdles
3Productivity
If endogenous progenitor cells are recruited using PDGF, then cell migration to scaffold is enhanced, but PDGF concentration optimization is required
Solution Approach 1:
The invention systematically investigates and optimizes PDGF concentration parameters (testing ranges from 10 ng/ml to 1000 ng/ml) to identify the optimal concentration that maximizes progenitor cell migration while minimizing costs and potential side effects
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method effectively recruits and differentiates progenitor cells into various tissue types, reducing the challenges associated with cell transplantation by utilizing the body's own cells for regeneration, demonstrating successful tissue repair and regeneration of tissues like bone, cartilage, and blood vessels.
Implementation Method 1
PDGF is a growth factor (i.e., a protein) that plays a role in embryonic development, cell proliferation, cell migration, and angiogenesis
Data Source
AI summary
Provided is a method of causing a cell to migrate to a scaffold. Also provided is a method of treating a mammal that has a tissue defect. Further provided is a tissue scaffold comprising platelet-derived growth factor (PDGF). Additionally, a method of making a tissue scaffold capable of recruiting a cell is provided.